PANCREATITIS AGUDA

XIMENA MARN QUINTERO UNIVERSIDAD DEL TOLIMA

Hospital Federico
DIEGO FERNANDO DURN UNIVERSIDAD DEL TOLIMA
Lleras Acosta
Caso Clnico

Paciente masculino de 40 aos

Cuadro clnico de 24 horas de evolucin
Dolor epigstrico de inicio progresivo que lleg
rpidamente a su mxima intensidad,
empeora con la palpacin y se atena al
inclinarse hacia delante
Sin antecedentes de importancia
Al examen fsico: dolor a la palpacin de
cuadrante superior derecho, abdomen
distendido, sin signos de irritacin peritoneal,
signo de murphy negativo
 Diagnstico diferencial dolor epigstrico

Anlisis 05
La pancreatitis puede distinguirse Isquemia mesentrica
Dolor periumbilical,
basndose en la clnica
caracterstica descrita y las
04 desproporcionado al examen fsico.
Pacientes con edad avanzada,
alteraciones en los valores de aterosclerosis, valvulopatas, IAM
reciente. La amilasa y lipasa no estn
laboratorio. Cuando no es claro el
cuadro se recurre a la imaginologa
03 tan elevadas

como la TAC contrastada Obstruccin intestinal

Dolor abdominal, anorexia, emesis biliosa, constipacin y
02 elevacin de amilasa y lipasa. Usualmente hay
antecedente de ciruga abdominal y/o hernias
Colecistitis
01 Dolor en cuadrante superior derecho irradiado a hombro derecho.
Hay signo de Murphy. La amilasa y lipasa no estan elevadas 3
veces lo normal
Coledocolitiasis o Colangitis
Transaminasas, bilirrubina y fosfatasa alcalina
elevadas. Amilasa y lipasa normales
lcera pptica
[3-7] Dolor epigstrico crnico e intermitente. No
irradiado a la espalda. La amilasa y lipasa estn
Enfoque Diagnstico [3-5]
Anamnesis

Antecedentes de colelitiasis, alcoholismo, hipertrigliceridemia,

uso de frmacos como diurticos, cido valprico o
sulfonamidas. Traumas abdominales previos, historia de
enfermedades autoinmunes
Pruebas de Laboratorio

Determinar la amilasa y lipasa sricas, niveles de triglicridos,

niveles de clcio y pruebas de funcin heptica.

Ecografa abdominal

A todo paciente con pancreatitis aguda para evaluar colelitiasis

o coldocolitiasis

Ecografa endoscpica o CPRE

Se realiza Colangiopancreatografa Endoscpica Retrgrada (CPRE) si se documenta colelitiasis o

coledocolitiasis. Ecografa endoscpica para evaluar anormalidades anatmicas, tumores o
Causas Principales

Mecnicas Frmacos Vasculares

[8-10] [21-25] [27]

Metablicas Txicas
[15-20] [26]

Alcohol Infecciones
[11-14] [26]

Trauma Congnita
[28] [29]
Epidemiologa [1,2]

Incidencia anual de 4.9 a 35 por 100.000 habitantes

Principal causa gastrointestinal de hospitalizacin en
USA MORTALIDAD

1 2 3 4
1. Mortalidad generalen paciente hospitalizado
2. Pancreatitis aguda leve 10% 1.5% 3% 30%
3. Pancreatitis intersticial
4. Pancreatitis necrotizante
 Etiologa

Obstruccin mecnica [8-10] Alcohol (30%) [11-14]

Clculos biliares (35-40%) Aumento de sntesis
Barro biliar (20%) enzimtica por clulas
Ascaris lumbricoides acinares pancreticas
Tumores pancreticos Sobresensibilizacin a la
colecistokinina

Toxinas [26] Idioptico (30%) [1,2]

Escorpiones Luego de una

(Centruroides, Tityus) investigacin
Araa reclusa marrn imaginolgica,
Actan por estimulacin serolgica y
colinrgica endoscpica
 Manifestaciones Clnicas [30-39]

Sntomas Clasificacin por

Dolor epigstrico severo y severidad
rpidamente progresivo, atenuado
al inclinarse hacia adelante Predictores de Severidad
Pancreatitis aguda leve-
Alcanza su mxima intensidad en ausencia de falla orgnica y/o Edad > 75a
10-20 minutos y perdura por horas complicaciones locales o Alcoholismo
a das sistmicas Irritacin
En un 50% de los pacientes se
Peritoneal
IMC > 30
irradia a la espalda Pancreatitis aguda moderada Dao Orgnico en las
Se asocia a nuseas y vmito Complicaciones locales o primeras 72h
Examen Fsico
(90%) sistmicas con falla orgnica
Hemoconcentracin
PCR > 150 en
Epigastrio sensible a la palpacin transitoria (<48 horas) 48h BUN > 20
Distensin abdominal
Creatinina
Disminucin de ruidos intestinales
Pancreatitis aguda severa Dao >1.8 Derrame
leo debido a inflamacin
orgnico persistente que Pleural
Escleras ictricas Ictericia
involucra uno o mltiples rganos
obstructiva debido a
coledocolitiasis
 Signos de sangrado retroperitoneal [30-32]

Ocurre con la complicacin de pancreatitis necrotizante

Grey Turner

Cullen

Reproduced from: Masha L, Bernard S. Cullen's sign suggesting retroperitoneal haemorrhage. Reproduced from: Masha L, Bernard S. Grey Turner's sign suggesting retroperitoneal haemorrhage.
Lancet 2014; 383:1920. Illustration used with the permission of Elsevier Inc. All rights reserved. Lancet 2014; 383:1920. Illustration used with the permission of Elsevier Inc. All rights reserved.
Scores de Severidad [30-35]
Hora 0
Edad >55
Criterios de Ranson
Recuento de leucocitos >16,000/mm3
para predecir la
severidad Glucosa sangunea >200 mg/dL
Lactato deshidrogenasa >350 U/L
Aspartato aminotransferasa >250 U/L
48 Horas
Hematocrito Cada 10%
La presencia de 1-3 BUN Aumento 5 mg/dL
criterios predice una Clcio srico < 8 mg/dL
pancreatitis aguda leve; pO2 < 60 mmHg
la mortalidad aumenta
significativamente con 4 Base exceso > 4 MEq/L
o mas Acumulacin de lquidos > 6000 mL
Scores de severidad
[30-35]

APACHE II
Acute Physiology And Chronic Health
Evaluation II
Clasificacin de Baltazar Radiolgica [30-35]

Grado de pancreatitis Necrosis pancretica Puntuacin

A: pncreas normal ninguna 0
Estratificacin
B: Agrandamiento del 1
pncreas Leve (intersticial)
C: Cambios 30% 2 Baltazar B o C sin
inflamatorios del necrosis pancretica o
pncreas y la grasa extrapancretica
peripancretica
Intermedia (pancreatitis
D: Coleccin de fluido 3
exudativa) Baltazar D
peripancretico
o E sin necrosis
simple y definida
pancretica
E: dos o mas 30-50% 4
colecciones Severa (Necrotizante)
peripancreticas Necrosis pancretica
poco definidas
> 50% 6
 Complicaciones locales [40-42]

Coleccin de fluido Pancreatitis Pancreatitis Pseudoquiste

peripancretico Necrotizante necrotizante infectada pancretico

Graphic 88436 Version 1.0

Graphic 88431 Version 2.0 Graphic 88434 Version 1.0 https://gi.jhsps.org/Upload/200802291655_2963_000.jpg

Coleccin necrtica aguda

(< 4 semanas)
Coleccin necrtica
encapsulada (> 4 semanas)
 Complicaciones sistmicas [43]

Segn la clasificacin de Atlanta, una complicacin sistmica es cualquier exacerbacin de una

comorbilidad subyacente (p,ej. Enfermedad coronaria o EPOC)

Falla Orgnica Score de Marshall modificado

Un puntaje de 2 o ms en cualquiera de los 3 sistemas orgnicos define una falla del mismo
Sistema Score
Orgnico
0 1 2 3 4

PaO2/FiO2 >400 301-400 201-300 101-200 101

Creatinina < 1,4 1,4 1,8 1,9 3,6 3,6 4,9 > 4,9
(mg/dL)
Presin arterial > 90 < 90, responde < 90, requiere < 90, pH < 7,3 < 90, pH < 7,2
sistlica mmHg a lquidos vasopresor
Diagnstico [44-49]

TAC abdominal
Clnica Lipasa o Amilasa Ecografa Abdominal
contrastado o
Resonancia magntica
Dolor epigstrico de Pancreas
Pncreas aumentado de tamao
inicio agudo, severo Elevacin 3 veces edematoso y
con hiperdensidades
y persistente mayor a lo normal agrandado, con heterogneas focales o difusas.

usualmente posible presencia de Si no hay hiperdensidad con

colelitiasis o contraste puede ser una
irradiado a la pancreatitis necrotizante
coledocolitiasis
Manejo de la Pancreatitis Aguda [50-56]

Lquidos Analgesia Nutricin Antibiticos

Cristaloides Opioides IV Reposo No profilaxis!

Isotnicos Fentanyl: bolos de Leve: suspender Microorganismos:
20-50 microgramos via oral hasta que E.coli,
5 10 mL/kg/h con intervalos de disminuya dolor. pseudomonas,
10 minutos. Retomar con dieta klebsiella,
Si hay hipotensin Infusin contnua: clara baja en enterococos
y taquicardia: 50-700 mcg/h grasa. Manejo dirigido:
20 mL/kg en 30 Hidromorfona: Moderada y Tincin Gram y
min y continuar a 0,2 1 mg cada 2- severa: Frmula Cultivo de aspirado
3 mL/kg/h por 12 h 3 horas en bolos elemental o semi- guiado por TAC
elemental por Manejo emprico:
sonda nasoyeyunal Carbapenmicos o
Quinolonas +
Metronidazol
Indicaciones de monitoreo en UCI [50-53]

Paciente con 1 o ms de los

siguientes
Pancreatitis aguda severa
APACHE II > 8 en las primeras 24
horas
Edad > 60 aos
FC < 40 o > 150 por minuto
PAS < 80 mmHg o PAM < 60 mmHg
FR > 35 por minuto
Sodio < 110 mmol/L o > 170 mmol/L
Potasio < 2.0 mmol/L o > 7.0 mmol/L
PaO2 < 50 mmHg
pH < 7,1 O > 7,7
Glicemia > 800 mg/dL
Calcio > 15 mg/dL
Anuria
Coma
 Intervenciones quirrgicas [55-60]

Intervenciones
Indicaciones Procedimientos
Pseudoquiste Drenajes
pancretico Endoscpico
Pancreatitis Percutneo con
necrotizante catter guiado por
infectada TAC
Pancreatitis Quirrgico
necrotizante (Cistogastrostoma,
encapsulada (>4 cistoenterostoma,
semanas) reseccin, necrosectoma)
Pancreatitis por CPRE / Colecistectoma
http://img.medscapestatic.com/pi/meds/ckb/25/10625tn.jpg
colelitiasis y
coledocolitiasis Embolizacin +
Pseudoaneurisma
Cuando sospechar un pseudoaneurisma:
reseccin
1. Sangrado gastrointestinal inexplicado
2. Expansin sbita de una coleccin necrtica encapsulada
3. Caida de hematocrito inexplicada
 Referencias bibliogrficas

1. Vege SS, Yadav D, Chari ST. Pancreatitis. In: GI Epidemiology, 1st ed, Talley NJ, Locke GR, Saito YA (Eds), Blackwell Publishing, Malden, MA 2007.
2. Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, Gangarosa LM, Thiny MT, Stizenberg K, Morgan DR, Ringel Y, Kim HP, Dibonaventura
MD, Carroll CF, Allen JK, Cook SF, Sandler RS, Kappelman MD, Shaheen NJ . Burden of gastrointestinal disease in the United States: 2012 update.
Gastroenterology. 2012 Nov;143(5):1179-87.e1-3. Epub 2012 Aug 8.
3. Forsmark CE, Baillie J, AGA Institute Clinical Practice and Economics Committee, AGA Institute Governing Board. AGA Institute technical review on acute
pancreatitis. Gastroenterology 2007; 132:2022.
4. Moreau JA, Zinsmeister AR, Melton LJ 3rd, DiMagno EP. Gallstone pancreatitis and the effect of cholecystectomy: a population-based cohort study. Mayo
Clin Proc 1988; 63:466.
5. Venneman NG, Renooij W, Rehfeld JF, et al. Small gallstones, preserved gallbladder motility, and fast crystallization are associated with pancreatitis.
Hepatology 2005; 41:738.
6. Tenner S, Dubner H, Steinberg W. Predicting gallstone pancreatitis with laboratory parameters: a meta-analysis. Am J Gastroenterol 1994; 89:1863.
7. Sharma VK, Howden CW. Metaanalysis of randomized controlled trials of endoscopic retrograde cholangiography and endoscopic sphincterotomy for the
treatment of acute biliary pancreatitis. Am J Gastroenterol 1999; 94:3211.
8. Opie EL. The etiology of acute hemorrhagic pancreatitis. Bull Johns Hopkins Hosp 1901; 12:182.
9. Lerch MM, Saluja AK, Rnzi M, et al. Pancreatic duct obstruction triggers acute necrotizing pancreatitis in the opossum. Gastroenterology 1993; 104:853.
10. Riela A, Zinsmeister AR, Melton LJ, DiMagno EP. Etiology, incidence, and survival of acute pancreatitis in Olmsted County, Minnesota. Gastroenterology 1991;
100:A296.
11. Yang AL, Vadhavkar S, Singh G, Omary MB. Epidemiology of alcohol-related liver and pancreatic disease in the United States. Arch Intern Med 2008; 168:649.
12. Apte MV, Wilson JS, McCaughan GW, et al. Ethanol-induced alterations in messenger RNA levels correlate with glandular content of pancreatic enzymes. J
Lab Clin Med 1995; 125:634.
13. Tiscornia OM, Celener D, Perec CJ, et al. Physiopathogenic basis of alcoholic pancreatitis: the effects of elevated cholinergic tone and increased
"pancreon" ecbolic response to CCK-PZ. Mt Sinai J Med 1983; 50:369.
14. Migliori M, Manca M, Santini D, et al. Does acute alcoholic pancreatitis precede the chronic form or is the opposite true? A histological study. J Clin
Gastroenterol 2004; 38:272.
 Referencias bibliogrficas

15. Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am 1990; 19:783.
16. Fortson MR, Freedman SN, Webster PD 3rd. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol 1995; 90:2134.
17. Scherer J, Singh VP, Pitchumoni CS, Yadav D. Issues in hypertriglyceridemic pancreatitis: an update. J Clin Gastroenterol 2014; 48:195.
18. Brandwein SL, Sigman KM. Case report: milk-alkali syndrome and pancreatitis. Am J Med Sci 1994; 308:173.
19. Khoo TK, Vege SS, Abu-Lebdeh HS, et al. Acute pancreatitis in primary hyperparathyroidism: a population-based study. J Clin Endocrinol Metab 2009; 94:2115.
20. Mithfer K, Fernndez-del Castillo C, Frick TW, et al. Acute hypercalcemia causes acute pancreatitis and ectopic trypsinogen activation in the rat. Gastroenterology 1995;
109:239.
21. Rnzi M, Layer P. Drug-associated pancreatitis: facts and fiction. Pancreas 1996; 13:100.
22. Wilmink T, Frick TW. Drug-induced pancreatitis. Drug Saf 1996; 14:406.
23. McArthur KE. Review article: drug-induced pancreatitis. Aliment Pharmacol Ther 1996; 10:23.
24. Spanier BW, Tuynman HA, van der Hulst RW, et al. Acute pancreatitis and concomitant use of pancreatitis-associated drugs. Am J Gastroenterol 2011; 106:2183.
25. Badalov N, Baradarian R, Iswara K, et al. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol 2007; 5:648.
26. Parenti DM, Steinberg W, Kang P. Infectious causes of acute pancreatitis. Pancreas 1996; 13:356.
27. Watts RA, Isenberg DA. Pancreatic disease in the autoimmune rheumatic disorders. Semin Arthritis Rheum 1989; 19:158.
28. Wilson RH, Moorehead RJ. Current management of trauma to the pancreas. Br J Surg 1991; 78:1196.
29. Gerson LB, Tokar J, Chiorean M, et al. Complications associated with double balloon enteroscopy at nine US centers. Clin Gastroenterol Hepatol 2009; 7:1177.
30. Swaroop VS, Chari ST, Clain JE. Severe acute pancreatitis. JAMA 2004; 291:2865.
31. Banks PA. Acute pancreatitis: Diagnosis. In: Pancreatitis, Lankisch PG, Banks PA (Eds), Springer-Verlag, New York 1998. p.75.
32. Banks PA, Freeman ML, Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006;
101:2379.
33. Lankisch PG, Schirren CA, Kunze E. Undetected fatal acute pancreatitis: why is the disease so frequently overlooked? Am J Gastroenterol 1991; 86:322.
34. Lankisch PG, Mller CH, Niederstadt H, Brand A. Painless acute pancreatitis subsequent to anticholinesterase insecticide (parathion) intoxication. Am J Gastroenterol 1990;
85:872.
35. Kesavan CR, Pitchumoni CS, Marino WD. Acute painless pancreatitis as a rare complication in Legionnaires disease. Am J Gastroenterol 1993; 88:468.
36. Mookadam F, Cikes M. Images in clinical medicine. Cullen's and Turner's signs. N Engl J Med 2005; 353:1386.
37. Dickson AP, Imrie CW. The incidence and prognosis of body wall ecchymosis in acute pancreatitis. Surg Gynecol Obstet 1984; 159:343.
38. Dahl PR, Su WP, Cullimore KC, Dicken CH. Pancreatic panniculitis. J Am Acad Dermatol 1995; 33:413.
39. Bennett RG, Petrozzi JW. Nodular subcutaneous fat necrosis. A manifestation of silent pancreatitis. Arch Dermatol 1975; 111:896.
 Referencias bibliogrficas

40. Easler J, Muddana V, Furlan A, et al. Portosplenomesenteric venous thrombosis in patients with acute pancreatitis is associated with pancreatic necrosis and
usually has a benign course. Clin Gastroenterol Hepatol 2014; 12:854.
41. Nadkarni NA, Khanna S, Vege SS. Splanchnic venous thrombosis and pancreatitis. Pancreas 2013; 42:924.
42. Harris S, Nadkarni NA, Naina HV, Vege SS. Splanchnic vein thrombosis in acute pancreatitis: a single-center experience. Pancreas 2013; 42:1251.
43. Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international
consensus. Gut 2013; 62:102.
44. Yadav D, Agarwal N, Pitchumoni CS. A critical evaluation of laboratory tests in acute pancreatitis. Am J Gastroenterol 2002; 97:1309.
45. Fortson MR, Freedman SN, Webster PD 3rd. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol 1995; 90:2134.
46. Frank B, Gottlieb K. Amylase normal, lipase elevated: is it pancreatitis? A case series and review of the literature. Am J Gastroenterol 1999; 94:463.
47. Dervenis C, Johnson CD, Bassi C, et al. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference.
Int J Pancreatol 1999; 25:195.
48. Lecesne R, Taourel P, Bret PM, et al. Acute pancreatitis: interobserver agreement and correlation of CT and MR cholangiopancreatography with outcome.
Radiology 1999; 211:727.
49. Arvanitakis M, Delhaye M, De Maertelaere V, et al. Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis.
Gastroenterology 2004; 126:715.
50. Gardner TB, Vege SS, Pearson RK, Chari ST. Fluid resuscitation in acute pancreatitis. Clin Gastroenterol Hepatol 2008; 6:1070.
51. Haydock MD, Mittal A, Wilms HR, et al. Fluid therapy in acute pancreatitis: anybody's guess. Ann Surg 2013; 257:182.
52. Wu BU, Hwang JQ, Gardner TH, et al. Lactated Ringer's solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin
Gastroenterol Hepatol 2011; 9:710.
53. Wu BU, Conwell DL. Acute pancreatitis part I: approach to early management. Clin Gastroenterol Hepatol 2010; 8:410.
54. Wu BU, Johannes RS, Sun X, et al. Early changes in blood urea nitrogen predict mortality in acute pancreatitis. Gastroenterology 2009; 137:129.
55. Talukdar R, Swaroop Vege S. Early management of severe acute pancreatitis. Curr Gastroenterol Rep 2011; 13:123.
 Referencias bibliogrficas

56. Trikudanathan G, Navaneethan U, Vege SS. Current controversies in fluid resuscitation in acute pancreatitis: a systematic review. Pancreas 2012;
41:827.
57. Gardner TB, Vege SS, Chari ST, et al. Faster rate of initial fluid resuscitation in severe acute pancreatitis diminishes in-hospital mortality.
Pancreatology 2009; 9:770.
58. Brown A, Baillargeon JD, Hughes MD, Banks PA. Can fluid resuscitation prevent pancreatic necrosis in severe acute pancreatitis? Pancreatology
2002; 2:104.
59. Whitcomb DC, Muddana V, Langmead CJ, et al. Angiopoietin-2, a regulator of vascular permeability in inflammation, is associated with
persistent organ failure in patients with acute pancreatitis from the United States and Germany. Am J Gastroenterol 2010; 105:2287.
60. Basurto Ona X, Rigau Comas D, Urrtia G. Opioids for acute pancreatitis pain. Cochrane Database Syst Rev 2013; :CD009179.